Mostly agree. I’d restate it to say that most retailers will hold on to a significant portion of their shares. I believe quite a few will still sell a little bit on UK approval spike to take some money off the table because you never know with the history of screw ups from this management.
Having said that, I don’t expect significant non dilutive funding from big pharma, unfortunately. So all of this is false hope and living in denial at this point.